Has Stephanie Teng, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,244 in general payments to Stephanie Teng, MD across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephanie Teng, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephanie Teng, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephanie Teng, MD

Otolaryngology · New York, NYNPI 1326483504

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,333 of the $3,244 with a category attached, or 71.9%. ZOLL Respicardia, Inc. accounts for 71.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $1,813 and has fallen 96.6% since, to $61 in 2025.

$3,244in general payments, 2019–2025

Across 12 payments — averaging $270.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ZOLL Respicardia, Inc.$2K
Steris Corporation$538
Integra Lifesciences Corporation$148
Merck$81
Olympus America Inc.$72
Medtronic$31
plus $41 from 2 others

What the payments were for

Consulting fees$2,33372%
Food & beverage$91128%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ZOLL Respicardia, Inc.	3	$2,333
Steris Corporation	2	$538
Integra Lifesciences Corporation	1	$148
Merck	1	$81
Olympus America Inc.	1	$72
Medtronic	2	$31
Pentax Of America, Inc.	1	$27
Axogen	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,244 in reported general payments places this provider in the 70th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York →

Medicare billing

Part B allowed, 2024

$93,259

Medicare patients

296

Services billed

888

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Omeprazole	103	$3,298
Azelastine Hcl	90	$3,133
Ipratropium Bromide	39	$1,181
Fluticasone Propionate	43	$797
Fluconazole	19	$226

Paid to pharmacies, not to this prescriber.

Other otolaryngology in New York

Roheen RaithathaNew York$830K
Dennis KrausNew York$159K
Anthony DelsignoreNew York$89K
Satish GovindarajNew York$39K
Lawrence LustigNew York$33K
Justin GolubNew York$30K
Brett MilesNew York$30K
David HiltzikNew York$25K
Milan AminNew York$23K
Ashutosh KackerNew York$20K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →